← Insider Monitor
Insight Molecular Diagnostics Inc. logo
IMDX

Insight Molecular Diagnostics Inc.

Nasdaq · In Vitro & In Vivo Diagnostic Substances

2
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Insight Molecular Diagnostics develops molecular diagnostic tests, including liquid biopsy technology used to detect and monitor cancer through blood-based biomarkers rather than traditional tissue biopsies.

Industry
In Vitro & In Vivo Diagnostic Substances
Headquarters
Nashville, TN
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
BROADWOOD PARTNERS, L.P.10% OwnerBuy$6.00MNov 17, 2026
BROADWOOD PARTNERS, L.P.10% OwnerBuy$0Nov 17, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for IMDX.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable IMDX activity by email

Free alerts for the insider and congressional trades worth watching.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.